Semi-Annual Statement Of Income And Retained Earnings

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7607422

Concept 2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2020-03-01 to
2021-02-28
2020-03-01 to
2021-02-28
2020-03-01 to
2021-02-28
2020-03-01 to
2021-02-28
2020-03-01 to
2021-02-28
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
8,615,000,000 JPY
9,337,000,000 JPY
9,438,000,000 JPY
10,671,000,000 JPY
Non-operating income
Non-operating income
2,531,000,000 JPY
3,453,000,000 JPY
1,526,000,000 JPY
2,061,000,000 JPY
Non-operating expenses
Non-operating expenses
538,000,000 JPY
152,000,000 JPY
591,000,000 JPY
903,000,000 JPY
Ordinary profit (loss)
10,608,000,000 JPY
12,638,000,000 JPY
10,372,000,000 JPY
11,829,000,000 JPY
Extraordinary income
Extraordinary income
660,000,000 JPY
660,000,000 JPY
188,000,000 JPY
408,000,000 JPY
Extraordinary losses
Extraordinary losses
1,331,000,000 JPY
342,000,000 JPY
22,000,000 JPY
40,000,000 JPY
Profit (loss) before income taxes
9,936,000,000 JPY
12,956,000,000 JPY
10,538,000,000 JPY
12,197,000,000 JPY
Income taxes - current
3,394,000,000 JPY
3,727,000,000 JPY
2,059,000,000 JPY
2,382,000,000 JPY
Income taxes - deferred
-627,000,000 JPY
-633,000,000 JPY
136,000,000 JPY
381,000,000 JPY
Profit (loss)
7,169,000,000 JPY
7,169,000,000 JPY
7,169,000,000 JPY
9,862,000,000 JPY
7,169,000,000 JPY
8,342,000,000 JPY
8,342,000,000 JPY
8,342,000,000 JPY
8,342,000,000 JPY
9,433,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.